Literature DB >> 2200843

Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.

F Castex1, G Corthier, S Jouvert, G W Elmer, F Lucas, M Bastide.   

Abstract

The ability of Saccharomyces boulardii to protect mice against intestinal pathology caused by toxinogenic Clostridium difficile was studied. Different regions of the intestine of experimental mice were prepared for observation by scanning electron microscopy or homogenized for C. difficile enumeration and quantification of toxin A by enzyme immunoassay and toxin B by cytotoxicity. The test group was treated for 6 d with an S. boulardii suspension in drinking water and challenged with C. difficule on day 4. The three control groups were: axenic mice, mice treated with only S. boulardii and mice only challenged with C. difficile. The results showed that: (i) 70% of the mice infected by C. difficile survived when treated with S. boulardii; (ii) the C. difficile-induced lesions on the small and large intestinal mucosa were absent or markedly less severe in S. boulardii-treated mice; and (iii) there was no decrease in the number of C. difficile but rather a reduction in the amount of toxins A and B in S. boulardii-treated mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200843     DOI: 10.1099/00221287-136-6-1085

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  11 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.

Authors:  I Castagliuolo; M F Riegler; L Valenick; J T LaMont; C Pothoulakis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.

Authors:  A Qamar; S Aboudola; M Warny; P Michetti; C Pothoulakis; J T LaMont; C P Kelly
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Caspase activation as a versatile assay platform for detection of cytotoxic bacterial toxins.

Authors:  Angela M Payne; Julie Zorman; Melanie Horton; Sheri Dubey; Jan ter Meulen; Kalpit A Vora
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

5.  Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.

Authors:  I Castagliuolo; J T LaMont; S T Nikulasson; C Pothoulakis
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.

Authors:  G Corthier; M C Muller; T D Wilkins; D Lyerly; R L'Haridon
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat.

Authors:  F Izadnia; C T Wong; S A Kocoshis
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

8.  Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

Authors:  Theodoros Kelesidis; Charalabos Pothoulakis
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.802

9.  Antimicrobial and probiotic properties of yeasts: from fundamental to novel applications.

Authors:  Rima Hatoum; Steve Labrie; Ismail Fliss
Journal:  Front Microbiol       Date:  2012-12-19       Impact factor: 5.640

10.  Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.

Authors:  Hon Wai Koon; Bowei Su; Chunlan Xu; Caroline C Mussatto; Diana Hoang-Ngoc Tran; Elaine C Lee; Christina Ortiz; Jiani Wang; Jung Eun Lee; Samantha Ho; Xinhua Chen; Ciaran P Kelly; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-11       Impact factor: 4.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.